Infertility News and Research RSS Feed - Infertility News and Research

Infertility primarily refers to the biological inability of a person to contribute to conception. Infertility may also refer to the state of a woman who is unable to carry a pregnancy to full term.
Smoking and genetics can increase women's likelihood of giving birth to twins

Smoking and genetics can increase women's likelihood of giving birth to twins

African American mothers who smoke and have a genetic profile that includes a single nucleotide polymorphism (SNP) of the TP53 gene have an increased likelihood of having twins, concluded a team of researchers from the University of South Florida and the University of Illinois at Urbana-Champaign. [More]
Two radiologists win Society of Interventional Radiology Foundation Leaders in Innovation Award

Two radiologists win Society of Interventional Radiology Foundation Leaders in Innovation Award

Two visionaries of interventional radiology were recently awarded the Society of Interventional Radiology Foundation Leaders in Innovation Award. The awards, to Lindsay Machan, M.D., FSIR, an interventional radiologist at Vancouver Hospital, British Columbia, and Kieran J. Murphy, M.D., FSIR, an interventional radiologist at the University of Toronto, both in Canada, were announced March 4 during the society's Annual Scientific Meeting in Atlanta. [More]
Study pinpoints how body clock genes could lead to recurrent miscarriages

Study pinpoints how body clock genes could lead to recurrent miscarriages

Researchers at the University of Warwick and UHCW have discovered how body clock genes could affect women's ability to have children. [More]
Merck Serono, Intrexon partner to develop and commercialize CAR-T cancer therapies

Merck Serono, Intrexon partner to develop and commercialize CAR-T cancer therapies

Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation, today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. [More]
Penn State surgeon provides guidelines for diagnosis, management of endometriosis

Penn State surgeon provides guidelines for diagnosis, management of endometriosis

Endometriosis is difficult to diagnose, with women often being told for years that they are experiencing their 'normal period.' According to the Endometriosis Foundation of America, it affects one in ten women. [More]
Discovery opens door to possible new ways to break transmission cycle of schistosomiasis

Discovery opens door to possible new ways to break transmission cycle of schistosomiasis

Researchers at Oregon State University have discovered a group of genes in one species of snail that provide a natural resistance to the flatworm parasite that causes schistosomiasis, and opens the door to possible new drugs or ways to break the transmission cycle of this debilitating disease. [More]
RMANJ acquires IVF New Jersey

RMANJ acquires IVF New Jersey

Reproductive Medicine Associates of New Jersey, a world-renowned leader in the field of infertility, today announced the strategic acquisition of IVF New Jersey Fertility and Gynecology Center, one of the largest fertility centers in New Jersey. [More]
New research initiative seeks to speed up implementation of health care policy for women veterans

New research initiative seeks to speed up implementation of health care policy for women veterans

As more women veterans seek health care in the Veterans Administration system, effective approaches are needed to ensure that their unique needs are recognized and met. A special April supplement to Medical Care collects new studies from an ongoing research initiative to inform health care policy for women veterans. [More]
Comprehensive review of sex hormones' role in female reproductive tract

Comprehensive review of sex hormones' role in female reproductive tract

Charles R. Wira, PhD, and colleagues at Dartmouth's Geisel School of Medicine have presented a comprehensive review of the role of sex hormones in the geography of the female reproductive tract and evidence supporting a "window of vulnerability" to HIV and other sexually transmitted infections (STIs). [More]
BU study explores birth outcomes for women who receive fertility treatment

BU study explores birth outcomes for women who receive fertility treatment

Birth outcomes for babies whose mothers used assisted reproductive technology (ART) are better in some cases, and worse in others, than for subfertile women who did not use ART, according to a first-of-its-kind study led by Boston University School of Public Health researchers. [More]
Letrozole helps restore fertility in obese, infertile men

Letrozole helps restore fertility in obese, infertile men

A letrozole pill once a week restored fertility in obese, infertile men and led to their partners giving birth to two full-term, healthy babies, according to a new study from Canada. The results will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego. [More]
Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

Exposure to endocrine-disrupting chemicals estimated to cost EU €157 billion a year

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism. [More]
Phthalate exposure in pregnancy adversely affects masculinization of male genitals in babies

Phthalate exposure in pregnancy adversely affects masculinization of male genitals in babies

Exposure to hormone-altering chemicals called phthalates - which are found in many plastics, foods and personal care products - early in pregnancy is associated with a disruption in an essential pregnancy hormone and adversely affects the masculinization of male genitals in the baby, according to research led by the University of Pittsburgh Graduate School of Public Health. [More]
Researchers one step closer to unraveling complex processes crucial to sperm development

Researchers one step closer to unraveling complex processes crucial to sperm development

Researchers are one step closer to unraveling the extraordinarily complex series of processes that leads to an event crucial to human reproduction: the creation of sperm. [More]
Adding goserelin drug to chemotherapy prevents early menopause in young women with breast cancer

Adding goserelin drug to chemotherapy prevents early menopause in young women with breast cancer

Early menopause can be prevented and fertility may be preserved in young women with early stage breast cancer, according to a study published today in The New England Journal of Medicine [More]
Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration. [More]
New conference to discuss ways of abolishing female genital mutilation in the UK

New conference to discuss ways of abolishing female genital mutilation in the UK

'We believe that education is the way forward to eradicate FGM. Therefore, in this symposium we are also launching an educational package for both professionals and communities alike'- Sadiyo Siad, FGM survivor, activist and campaigner. [More]
FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, today announced the approval of LILETTA (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration for use by women to prevent pregnancy for up to three years. [More]
Epigenetics and women’s health research: an interview with Professor Steve Conlan, Swansea University

Epigenetics and women’s health research: an interview with Professor Steve Conlan, Swansea University

Our research into gynaecological oncology focuses around understanding mechanisms of how genes are regulated or how they become dysregulated in a disease; and also the effects that has on the surface of the endometrium and also the function of the ovaries... [More]
Cervical treatment procedures do not affect fertility, shows study

Cervical treatment procedures do not affect fertility, shows study

Common surgical procedures used to diagnose and treat precancerous cervical lesions do not decrease women's chances of becoming pregnant, according to a study that followed nearly 100,000 women for up to 12 years. [More]
Advertisement
Advertisement